Replies to post #799249 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

JerryCampbell,

NWBO just covering all the bases which leaves the door open for MHRA. Regulators like that even if they don’t decide to go through it; ). Best wishes.

[CherryTree1]

AI disagrees with you.

Northwest Biotherapeutics (NWBO) SEC filings include "equivalency studies" as a risk factor, noting that changes in manufacturing methods could necessitate such studies or additional clinical trials. However, recent filings indicated no regulatory friction regarding "comparability" during the review process for its Marketing Authorization Application. You can find NWBO's official SEC filings through the SEC's EDGAR database.